These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3509959)
21. [Experimental research on the action of a derivative from a p-chloropenoxyisobutyric acid series on lipid parameters]. Filip M; Hriscu A; Păduraru I; Rusu M Rev Med Chir Soc Med Nat Iasi; 1986; 90(1):156-60. PubMed ID: 3764166 [No Abstract] [Full Text] [Related]
22. [The hypolipidemic and antiatherosclerotic properties of the ammonium salt of glycyrrhetic acid and of 18-dehydroglycyrrhetic acid]. Zakirov UB; Abdullaev AKh Eksp Klin Farmakol; 1996; 59(5):53-5. PubMed ID: 9026213 [TBL] [Abstract][Full Text] [Related]
23. [A clofibric acid derivative with hypolipemic and platelet antiaggregant action]. Dănilă G; Nechifor M; Filip M; Păduraru I; Ifrim C; Grădinariu D; Papa V; Manolescu A; Bădescu A Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):127-32. PubMed ID: 3393745 [No Abstract] [Full Text] [Related]
24. The effective of active principle of garlic and onion on blood lipids and experimental atherosclerosis in rabbits and their comparison with clofibrate. Bordia A; Verma SK; Khabia BL; Vyas A; Rathore AS; Bhu N; Bedi HK J Assoc Physicians India; 1977 Aug; 25(8):509-16. PubMed ID: 614376 [No Abstract] [Full Text] [Related]
25. [Experimental study of anti-atherosclerosis potency by lycium seed oil and its possible mechanism]. Jiang YD; Cao J; Dong QZ; Wang SR Zhong Yao Cai; 2007 Jun; 30(6):672-7. PubMed ID: 17918438 [TBL] [Abstract][Full Text] [Related]
26. [Studies on the lipid metabolism in experimental arteriosclerosis--relationship of hyperlipemia and plasma fatty acid compostion with development of atherosclerosis]. Hao H Jpn Circ J; 1968 Dec; 32(12):1767-76. PubMed ID: 5756571 [No Abstract] [Full Text] [Related]
27. Serum lipid picture of rabbits fed on silicate-supplemented atherogenic diet. Trincă L; Popescu O; Palamaru I Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):99-102. PubMed ID: 10756893 [TBL] [Abstract][Full Text] [Related]
28. [Effect of acoustic stimulation on lipid metabolism, indices of the blood coagulation system and development of experimental atherosclerosis in rabbits]. Deriagina GP; Sinitsyna TS; Veselova TV Fiziol Zh SSSR Im I M Sechenova; 1976 Aug; 62(8):1171-81. PubMed ID: 186333 [TBL] [Abstract][Full Text] [Related]
29. A search for a model of experimental atherosclerosis: comparative studies in rabbits, guinea pigs and rats. Wójcicki J; Samochowiec L; Jaworska M; Hinek A Pol J Pharmacol Pharm; 1985; 37(1):11-21. PubMed ID: 4034437 [TBL] [Abstract][Full Text] [Related]
30. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)]. Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060 [TBL] [Abstract][Full Text] [Related]
31. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias]. Machalke K; Djaja S; Richter E Ther Ggw; 1982 May; 121(5):301-11. PubMed ID: 6953613 [No Abstract] [Full Text] [Related]
32. Experimental pharmacological study of moroxybrate, a hypolipidaemic, antithrombotic, antiatheromatous agent. Moreau P; Jacotot B; Tillement JP J Pharm Pharmacol; 1987 Jan; 39(1):35-8. PubMed ID: 2880981 [TBL] [Abstract][Full Text] [Related]
33. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients]. Rugginenti Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840 [No Abstract] [Full Text] [Related]
34. [Lipids and atherosclerosis]. González Santos P; De la Higuera Rojas J Rev Clin Esp; 1974 Mar; 132(5):387-98. PubMed ID: 4208680 [No Abstract] [Full Text] [Related]
35. Confirmation of efficacy of etofibrate against peripheral atherosclerosis in non-human primates which model human lesion types I-VII. Fincham JE; Quack G; Wülfroth P; Benadé AJ Arzneimittelforschung; 1996 May; 46(5):519-25. PubMed ID: 8737639 [TBL] [Abstract][Full Text] [Related]
36. The effect of benactyzine and meprobamate on the development of experimental atherosclerosis in rabbits. Cuparencu B; Mocan R; Safta L Cor Vasa; 1973; 15(2):136-45. PubMed ID: 4717920 [No Abstract] [Full Text] [Related]
37. [Experimental atherosclerosis by high cholesterol diet: long term development (studies in rabbits)]. Dallocchio M; Crockett R; Razaka G; Sallenave M; Nicouleau P; Bricaud H; Broustet P Rev Atheroscler (Paris); 1969; 11(2):54-69. PubMed ID: 5403123 [No Abstract] [Full Text] [Related]
38. [The influence of orotic acid on the concentration of cholesterol and total lipids in the blood and organs of rabbits with experimental atherosclerosis]. Kaĭdin DA Farmakol Toksikol; 1973; 36(5):571-4. PubMed ID: 4788065 [No Abstract] [Full Text] [Related]
39. [Hypolipemic effect of amino acid derivatives of clofibric acid]. Wójcicki J; Samochowiec L; Gawrońska-Szklarz B; Kwapiszewski W; Borkowski L Acta Pol Pharm; 1985; 42(3):305-8. PubMed ID: 4096253 [No Abstract] [Full Text] [Related]
40. Inhibition of cholesterol-induced atherosclerosis in rabbits by dimethyl sulfoxide. Debons AF; Fani K; Jimenez FA; Maayan ML J Pharmacol Exp Ther; 1987 Nov; 243(2):745-57. PubMed ID: 3681702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]